Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-22-072187

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rubin Steven D · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-15 Grant or award : show line 1 in the form Stock Options (Right to Buy) +20,000 20,000 D
Loading xslF345X03/tm2218714-5_4seq1.xml…